StudyFinder

Effect and safety of liraglutide 3.0 mg on weight management in children with obesity aged 6 to < 12 years: 56-week, double-blind, randomised, placebo-controlled trial

Recruiting

This study will compare the effect of liraglutide 3.0 mg subcutaneous once daily versus liraglutide placebo on weight management in children aged 6 to <12 years with placebo. The study will also compare the effect of liraglutide 3.0 mg s.c. once daily versus placebo in children aged t to 12 years with obesity on cardiovascular risk factors and metabolism.

I'm interested

This study is NOT accepting healthy volunteers

Obesity, Childhood

Obesity

Claudia Fox - lusc0001@umn.edu
Claudia Fox
Phase III
STUDY00011812
NCT04678323
See this study on ClinicalTrials.gov

Back